Regulations.gov document
Response to Siri & Glimstad LLP form FDA CBER
Other · FDA-2020-P-1601 · posted Jun 18, 2021
Key facts
| Document ID | FDA-2020-P-1601-0071 |
|---|---|
| Title | Response to Siri & Glimstad LLP form FDA CBER |
| Document type | Other |
| Subtype | Response(s) |
| Agency | FDA |
| Docket | FDA-2020-P-1601 |
| Posted | Jun 18, 2021 |
| Comment period opens | Jun 22, 2021 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: